Aims & Scope
The Breast is an international, multidisciplinary journal for researchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer prevention, diagnosis and treatment of all stages.
The Editors welcome the submission of original research articles, systematic reviews, and viewpoint/commentary and debate articles, and correspondence on all areas of pre-malignant and malignant breast disease, including: • Epidemiology and prevention • Translational research, encompassing the use of new technologies, molecular biology, genetics and pathology • Screening, early diagnosis, follow-up and response assessment: use of imaging, nuclear medicine and other technologies • Medical oncology • Radiation oncology • Breast surgery • Psycho-oncology • Quality of life • Survivorship • Supportive care • Palliative and end-of-life care • Advocacy • Breast Nursing • Breast Units management and organization of breast care, including health economics
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 7.9 |
2024 | 5.70 |
Journal Rank
Year | Value |
---|---|
2024 | 1065 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 3073 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 2.348 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,760.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Citation: 2173
Authors: Melina, Eileen, Harriet, Allini, Deependra, Mathieu, Jerome, Julie R., Fatima, Sabine, Isabelle
-
Clinical implications of the intrinsic molecular subtypes of breast cancer
Citation: 840
Authors: Aleix, Estela, Barbara, Patricia, Aranzazu, Lydia, Marc, Margarita, Ana, Montserrat
-
A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival
Citation: 781
Authors: Keith N, Iain D, Simon, Andrew W, Tarun K, Ian, A, Steven D
-
Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
Citation: 332
Authors: R., C., S.E., P.
-
Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective study
Citation: 313
Authors: Elisabeth Edström, Yvonne, Tina, Richard, Jakob, Göran, Marie, Kerstin
-
1st International consensus guidelines for advanced breast cancer (ABC 1)
Citation: 251
Authors: F., A., L., D., T., L., P., J., S., N., O., E., C., M., J., A., N., P.A., K., A., N., N., C., B., M., M., A., H., V., G., L., G., I., E.
-
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Citation: 249
Authors: F., A., L., E., M., F., C.H., J., L., K.L., M.J., T., N., L., D., P., K., S.H., J., A., N., N., C., B., I., S., U.N., M., S.D., E.B., O., A., F., M.J., H., G., C., L., D., C., N., B., E.
-
Overview of radiomics in breast cancer diagnosis and prognostication
Citation: 242
Authors: Alberto Stefano, Michele, Daniela, Rita, Anna Maria, Nehmat
-
The ethical, legal and social implications of using artificial intelligence systems in breast cancer care
Citation: 233
Authors: Stacy M., Wendy, Khin Than, Helen, Bernadette, Nehmat